BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32441462)

  • 1. Time to Step Up: A Call to Action For the Clinical and Quantitative Pharmacology Community to Accelerate Therapeutics for COVID-19.
    Hartman D; Kern S; Brown F; Minton SK; Rayner CR
    Clin Transl Sci; 2020 Jul; 13(4):646-648. PubMed ID: 32441462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19: A Defining Moment for Clinical Pharmacology?
    van der Graaf PH; Giacomini KM
    Clin Pharmacol Ther; 2020 Jul; 108(1):11-15. PubMed ID: 32350861
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 therapeutic options for patients with kidney disease.
    Izzedine H; Jhaveri KD; Perazella MA
    Kidney Int; 2020 Jun; 97(6):1297-1298. PubMed ID: 32317113
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19: Stay Cool toward Corticosteroids.
    Fujishima S
    Keio J Med; 2020 Jun; 69(2):27-29. PubMed ID: 32475851
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
    Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
    Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sofosbuvir for COVID-19 infection: A potential candidate.
    Gupta R; Dhamija P
    Indian J Pharmacol; 2020; 52(3):232-233. PubMed ID: 32874010
    [No Abstract]   [Full Text] [Related]  

  • 7. Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients.
    Rani S; Grover S; Mehra A; Sahoo S
    Indian J Pharmacol; 2020; 52(3):229-231. PubMed ID: 32874009
    [No Abstract]   [Full Text] [Related]  

  • 8. Covid-19 treatment update: follow the scientific evidence.
    Becker RC
    J Thromb Thrombolysis; 2020 Jul; 50(1):43-53. PubMed ID: 32338320
    [No Abstract]   [Full Text] [Related]  

  • 9. Recommendations for use of a hydroxychloroquine loading dose in patients with COVID-19.
    Kara E; Demirkan K; Unal S
    Int J Antimicrob Agents; 2020 Sep; 56(3):106123. PubMed ID: 32738307
    [No Abstract]   [Full Text] [Related]  

  • 10. Statins in coronavirus outbreak: It's time for experimental and clinical studies.
    Bifulco M; Gazzerro P
    Pharmacol Res; 2020 Jun; 156():104803. PubMed ID: 32289478
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach.
    Sarma P; Prajapat M; Avti P; Kaur H; Kumar S; Medhi B
    Indian J Pharmacol; 2020; 52(1):1-5. PubMed ID: 32201439
    [No Abstract]   [Full Text] [Related]  

  • 12. News Feature: To counter the pandemic, clinicians bank on repurposed drugs.
    Madhusoodanan J
    Proc Natl Acad Sci U S A; 2020 May; 117(20):10616-10620. PubMed ID: 32350142
    [No Abstract]   [Full Text] [Related]  

  • 13. Is the type of diabetes treatment relevant to outcome of COVID-19?
    Bloomgarden Z
    J Diabetes; 2020 Jul; 12(7):486-487. PubMed ID: 32353193
    [No Abstract]   [Full Text] [Related]  

  • 14. The coronavirus outbreak could make it quicker and easier to trial drugs.
    Ledford H
    Nature; 2020 Jun; 582(7811):172. PubMed ID: 32504019
    [No Abstract]   [Full Text] [Related]  

  • 15. Coronavirus disease 2019 infection and the cardiovascular system.
    Romeo F; Calcaterra G; Barilla F; Mehta JL
    J Cardiovasc Med (Hagerstown); 2020 Jun; 21(6):403-405. PubMed ID: 32324641
    [No Abstract]   [Full Text] [Related]  

  • 16. Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19.
    Oldenburg CE; Doan T
    Am J Trop Med Hyg; 2020 Jun; 102(6):1154-1155. PubMed ID: 32297590
    [No Abstract]   [Full Text] [Related]  

  • 17. Science in the Wake of the Pandemic: How Will COVID-19 Change the Way We Do Research?
    Mol Cell; 2020 Jul; 79(1):9-10. PubMed ID: 32619472
    [No Abstract]   [Full Text] [Related]  

  • 18. The challenging pathway towards the identification of SARS-CoV-2/COVID-19 therapeutics.
    Siccardi M; Schapiro J; Di Perri G; Back DJ
    J Antimicrob Chemother; 2020 Sep; 75(9):2381-2383. PubMed ID: 32591771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug targets for COVID-19 therapeutics: Ongoing global efforts.
    Saxena A
    J Biosci; 2020; 45(1):. PubMed ID: 32661214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All together to Fight COVID-19.
    Momtazmanesh S; Ochs HD; Uddin LQ; Perc M; Routes JM; Vieira DN; Al-Herz W; Baris S; Prando C; Rosivall L; Abdul Latiff AH; Ulrichs T; Roudenok V; Aldave Becerra JC; Salunke DB; Goudouris E; Condino-Neto A; Stashchak A; Kryvenko O; Stashchak M; Bondarenko A; Rezaei N
    Am J Trop Med Hyg; 2020 Jun; 102(6):1181-1183. PubMed ID: 32323644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.